Critical Therapeutics has decided to discontinue the manufacturing of Zyflo (zileuton) immediate-release tablets due to a decline in use.
News
Sciele Pharma has launched Fenoglide (fenofibrate) 40mg and 120mg tablets for the treatment of hyperlipidemia and hypertriglyceridemia.
King Pharmaceuticals has launched a tablet formulation of Altace (ramipril).
Abbott has received FDA approval for Simcor, a fixed-dose, single-pill combination of two cholesterol-lowering medications: Niaspan (niacin extended-release tablets) and simvastatin.
The FDA has approved a liquid formulation of the prescription antihistamine Xyzal (levocetirizine dihydrochloride, from UCB and sanofi-aventis).
Actavis has voluntarily recalled 14 lots of fentanyl transdermal system patches.
OrthoNeutrogena has launched a 60g tube of Renova (tretinoin 0.02%) cream in addition to the 40g tube already available.
KwikPen, a prefilled, portable insulin pen for use with Lilly’s Humalog (insulin lispro injection [rDNA origin]) brand of insulins, is now available.
Perrigo has received FDA approval to market the generic version of Pepcid Complete chewable tablets (famotidine 10mg, calcium carbonate 800mg, and magnesium hydroxide 165mg, from Johnson & Johnson-Merck Consumer).
All lots of Duragesic 25mcg/hr from PriCara and fentanyl 25mcg/hr patches from Sandoz have been voluntarily recalled.
- Loading...
